(Q39062237)

English

The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma

scientific article published on 29 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Elke Pogge von Strandmann

17

object named as

Elke Pogge von Strandmann

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sampurna Chatterjee

object named as

Sampurna Chatterjee

10

0 references

16

object named as

Michael Hallek

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Achim Rothe

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ron D Jachimowicz

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sven Borchmann

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Marie Madlener

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jörg Keßler

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Katrin S Reiners

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Maike Sauer

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Hinrich P Hansen

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Roland T Ullrich

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Peter Borchmann

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Paul Yazaki

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Thomas C Koslowsky

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Andreas Engert

14

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Lukas C Heukamp

15

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

29 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

134

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

2829-2840

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Antibody-based therapy for solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Up on the tightrope: natural killer cell activation and inhibition

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Prospects for the use of NK cells in immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

UL16 binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Soluble NKG2D ligands: prevalence, release, and functional impact.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Effect of NKG2D ligand expression on host immune responses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

NK cells interactions with dendritic cells shape innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Natural killer cell-directed therapies: moving from unexpected results to successful strategies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Emerging natural killer cell immunotherapies: large-scale ex vivo production of highly potent anticancer effectors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Use of allogeneic NK cells for cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Densely granulated murine NK cells eradicate large solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Tumor-associated MICA is shed by ADAM proteases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Identifiers

10.1002/IJC.28609

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39062237&oldid=1806154232"